ClinicalTrials.gg
CompletedNCT06316999Updated Aug 12, 2026Results posted

Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis

An interventional study of Intestinal Ultrasound in Ulcerative Colitis and Pouchitis, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Intestinal ultrasound (IUS) has been studied in the evaluation of inflammatory bowel disease (IBD) and is increasingly used as a non-invasive, easy to use, cost-effective tool for point-of-care to assess disease activity and more recently to predict response to treatment. However, there is a paucity of data on the use of IUS specifically for ulcerative colitis (UC) patients with an ileal pouch-anal anastomosis (IPAA).

Read the detailed description

AIMS:

  1. Establish normal sonographic parameters in patients with an IPAA and normal pouch function.
  2. Evaluate the feasibility of IUS for diagnosing pouchitis and other outcomes and compare its performance with the current gold standard of pouchoscopy with biopsies.
02

Conditions studied

  • Ulcerative Colitis
  • Pouchitis

Keywords

  • Ileal Pouch Anal Anastomosis
03

In context

Colitis, Ulcerative

1,853 studies on the registry are indexed under Colitis, Ulcerative; 472 are open to participants now.

This study's enrollment of 66 is close to the median of 70 across 1,236 interventional studies indexed under Colitis, Ulcerative.

Browse Colitis, Ulcerative studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.

Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (age ≥ 18 years)
  • Diagnosis of ulcerative colitis (UC)
  • Status post ileal pouch anal anastomosis IPAA (completed all stages)

Exclusion criteria

Exclusion Criteria:

  • Pediatric patients
  • Indeterminate colitis
  • Status post IPAA for familial adenomatous polyposis (FAP)
  • > 30 kg/m2
  • Pregnant
  • Decompensated Cirrhosis
  • Inability to provide
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • Other
    Patients with Pouchitis

    Transabdominal and trans perianal ultrasounds of the pouch will be performed by an experienced sonographer for each patient and interpreted by a board-certified radiologist specializing in IUS.

    Diagnostic Test: Intestinal Ultrasound

Interventions

  • Diagnostic testIntestinal Ultrasound

    Transabdominal and trans perineal ultrasound of the pouch

06

What researchers measure

Primary outcomes

  1. Diagnostic Accuracy of Intestinal Ultrasound (IUS) to Evaluate for Pouchitis Findings, Post Ileal Pouch-Anal Anastomosis-Number of Participants With Abnormal Ultrasound Findings

    Radiologists were blinded to pouchoscopy with biopsy results and evaluated the intestinal ultrasound of the pouch for each patient; assessing whether normal healthy pouch or inflammation was present. Those results were then compared to gold standard of pouchoscopy with biopsies to confirm accuracy. The number (n(%)) of participants with abnormal ultrasound findings confirmed with gold standard are reported.

    Time frame: 2 hours per subject for ultrasound.

07

Results

Posted Aug 12, 2026

Participant flow

protocol goal was to enroll 109, only 66 subject signed consent, and took part in the study.

Participant flow — Overall Study
MilestonePatients With Pouchitis
Started66
Completed55
Not completed11
Withdrew: Technical issue with ultrasound recording, data not used for analysis11

Outcome measures

PrimaryDiagnostic Accuracy of Intestinal Ultrasound (IUS) to Evaluate for Pouchitis Findings, Post Ileal Pouch-Anal Anastomosis-Number of Participants With Abnormal Ultrasound Findings

Radiologists were blinded to pouchoscopy with biopsy results and evaluated the intestinal ultrasound of the pouch for each patient; assessing whether normal healthy pouch or inflammation was present. Those results were then compared to gold standard of pouchoscopy with biopsies to confirm accuracy. The number (n(%)) of participants with abnormal ultrasound findings confirmed with gold standard are reported.

Time frame:
2 hours per subject for ultrasound.
Reported as:
Number · participants
Diagnostic Accuracy of Intestinal Ultrasound (IUS) to Evaluate for Pouchitis Findings, Post Ileal Pouch-Anal Anastomosis-Number of Participants With Abnormal Ultrasound Findings
participantsPatients With Pouchitis
Diagnostic Accuracy of Intestinal Ultrasound (IUS) to Evaluate for Pouchitis Findings, Post Ileal Pouch-Anal Anastomosis-Number of Participants With Abnormal Ultrasound Findings33

Adverse events

Collected over 9 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Patients With Pouchitis0/55 (0%)0/55 (0%)0/55 (0%)

Baseline characteristics

unable to use information from 11 participants due to ultrasound technique.

Age, Categorical
Age, Categorical(Participants)Patients With Pouchitis
<=18 years0
Between 18 and 65 years34
>=65 years21
Age, Continuous
Age, Continuous(age)Patients With Pouchitis
Mean55.11 (26.62 to 83.6)
Sex: Female, Male
Sex: Female, Male(Participants)Patients With Pouchitis
Female19
Male36
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Patients With Pouchitis
08

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55905, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06316999
Lead sponsor
Mayo Clinic
Responsible party
Darrell S. Pardi, M.D. (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Mar 19, 2024
Start date
Jul 1, 2024
Primary completion
Jun 4, 2025
Completion
Dec 4, 2025
Results posted
Aug 12, 2026
Last update
Aug 12, 2026

Study contacts

Darrell Pardi, MD
principal investigator · Mayo Clinic

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion